Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose vs Standard Dose Insulin in Adult DKA
NCT05443802Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2022
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of human insulin in diabetic ketoacidosis (DKA) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Metabolic complications at 48 hours. Started Aug 2022; status: completed.
02
Drugs
human insulin
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on NCT05443802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05443802.